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The relationship between maize con-
sumption and risk of cancer of the up-
per digestive tract was investigated in
107 patients with oral cancer, 107 with
pharyngeal cancer, 68 with esophageal
cancer, and 505 hospital controls who
permanently resided in Pordenone
Province in the northeastern part of
Italy. The analysis was restricted to
males. The population of this province
has a high incidence of these neoplasms
and shows particularly elevated levels of
alcohol and tobacco use, in addition to
high maize consumption. Highly signif-
icant associations with frequent intake
of maize emerged for oral cancer, pha-
ryngeal cancer, and esophageal cancer
(odds ratios = 3.3,3.2, and 2.8, respec-
tively). The risk elevation could not be
explained in terms of differences in ed-
ucation, occupation, tobacco use, or
consumption of fresh fruits and vegeta-
bles. The unfavorable effect of maize on
risk of cancer of the upper digestive
tract, however, was evident only in
those individuals who reported heavy
drinking (i.e., 2*42 alcoholic drinks/
wk). The present findings are likely to
be related to the fact that maize can
cause deficiencies of various micronu-
trients (chiefly, niacin and riboflavin)
and agree with previous observations
from Africa, the People's Republic of
China, the United States, and Italy. [J
Nati Cancer Inst 82:1407-1411,1990]
Alcohol and tobacco are two of the best
known agents that have been implicated in
the etiology of cancers of the upper diges-
tive tract (UDT) (i.e., oral cavity, phar-
ynx, and esophagus) (7-5). However,
there are areas outside Europe and North
America with a very high incidence of
UDT cancers, particularly esophageal
cancer, in which alcohol and tobacco play
a negligible role in the causation of the
cancers; therefore, interest has focused on
the manner in which poor diets may in-
crease the risk of these cancers (5-77).
Some studies {16,18) have considered
various macronutrient and micronutrient
deficiencies or imbalances in the etiology
of esophageal cancer. Other studies con-
ducted in various parts of the world
(7,9,11,12,19), including the northeastern
part of Italy (20), have suggested that the
geographical and temporal distributions,
at least of esophageal cancer, could reflect
the use of maize as the major staple food as
well as the use of maize for brewing beer.
The present case-control study was
conducted in Pordenone Province in the
Friuli-Venezia Giulia region of the north-
eastern part of Italy. This area has the
highest mortality rates for UDT cancers in
Italy (standardized mortality ratios of 266
and 229 for oral and pharyngeal cancers
and esophageal cancer, respectively, in
males, with the entire male population of
Italy having standardized mortality ratios
of 100) (21). In addition, this area has
UDT cancer rates that are among the most
elevated in Europe (standardized mortality
rates being 23.8 per 100,000 males for
cancers of the oral cavity and pharynx and
16.6 per 100,000 males for esophageal
cancer) (27).
Over 75% of the UDT cancers in north-
em Italy seem to be attributable to alcohol
and tobacco use (5). This region of Italy
offers also one of the few examples of a
highly developed area where maize (i.e.,
sweet com or Indian com) has traditionally
been and, to a certain extent, still is the
cereal most widely grown and eaten in the
form of polenta (22,23). In the framework
of a multihypothesis case-control surveil-
lance study, we were thus able to explore
in this region the influence of a high intake
of maize on the risk of developing UDT
cancers, allowing for the presence of other
risk factors (chiefly, alcohol use).
Patients and Methods
Since June 1985, we have been con-
ducting a case-control study on patients
with UDT cancers in the province of Por-
denone. Trained interviewers identified
and questioned patients who were (a) ad-
mitted for historically confirmed UDT
cancers (and a wide variety of other condi-
tions) to the Aviano Cancer Center and all
other local hospitals, (b) below age 75
years, and (c) permanent residents in Por-
denone Province. Approximately 3% of
the patients and 4% of the controls refused
to participate. The area studied is not
covered by a cancer registry, and it was not
possible to estimate the proportion of pa-
tients with UDT cancers interviewed.
However, the study hospitals comprised
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all the diagnostic and therapeutic facilities
available in the province; therefore, the
majority of cancer patients would have
been referred to one of these hospitals.
Furthermore, 90% of the patients were
interviewed within 2 months from diagno-
sis of cancer, thus minimizing losses
caused by patient deaths.
The present analysis was restricted to
males, who represented 89% of the inter-
viewed individuals. The analysis was
based on 107 patients with cancer of the
tongue and oral cavity [International Clas-
sification of Diseases, 9th revision (ICD)
= 140, 141, 143, 144, and 145; median
age = 60 yr]; 107 patients with cancer of
the pharynx, the junction between the hy-
popharynx and the larynx included (ICD
= 146, 148, and 161.1; median age = 59
yr); 68 patients with cancer of the esopha-
gus (ICD = 150; median age = 62 yr); and
505 hospital controls (median age = 58 yr)
interviewed before November 1989 (table
1). Of these controls, 25% were admitted
for traumatic conditions, 22% for orthope-
dic conditions, 19% for infections or acute
surgical conditions, 14% for skin diseases,
and 20% for other illnesses (e.g., disor-
ders of the ear, nose, or teeth). Excluded
from the comparison group were patients
whose diagnosis causing the current ad-
mission was of a malignant disorder, of a
disease related to alcohol and/or tobacco
consumption, or of a condition that might
have resulted in diet modifications.
The questionnaire concerned socio-
demographic indicators and personal hab-
its such as smoking and frequency of
consumption per week of alcoholic bever-
ages (i.e., wine; beer, and hard liquors,
separately) and 40 selected indicator
foods, including major sources of pro-
teins, fats, fibers, methylxanthines, and
vitamins A and C in the Italian diet. Ques-
tions on dietary and drinking habits re-
ferred to the year before the onset of the
symptoms of the disease that led to hospi-
tal admission.
The case-control studies were analyzed
by standard statistical methods (24-27).
TaWe 1. Distribution of 282 patients with UDT cancers and 505 controls according
to sociodemographic factors and smoking and drinking habits: Pordenone, Italy, 1985-1989
Age (yr)
<54
55-64
>65
Education (yr)||
<4
5-6
>7
Occupation
Clerical-professional worker
Industrial worker
Farmer
Smoking habits||
Never smokers
Exsmokers
Pipe-cigar smokers
Cigarette smokers
<15/day
15-24/day
>25/day
Alcoholic drinks/wkll'U
<41
42-76
>77
Oral
No.*
36
38
33
27
57
22
24
50
33
4
5
3
22
44
27
16
50
41
Patients by site of cancer
cavity
%
33.6
35.5
30.8
25.5
53.8
20.8
22.4
46.7
30.8
3.8
4.8
2.9
21.0
41.9
25.7
15.0
46.7
38.3
Pharynx
Nat
37
44
26
23
58
26
25
61
21
1
10
0
22
48
26
17
38
51
%
34.6
41.1
24.3
21.5
54.2
24.3
23.4
57.0
19.6
0.9
9.3
0.0
20.6
44.9
24.3
16.0
35.8
48.1
Esophagus
No.t
17
28
23
19
40
9
13
40
15
3
13
1
13
26
12
10
28
30
%
25.0
41.2
33.8
27.9
58.8
13.2
19.1
58.8
22.1
4.4
19.1
1.5
19.1
38.2
17.6
14.7
41.2
44.1
Controls
No.§
186
192
127
99
249
157
143
287
75
96
112
2
104
134
56
208
183
113
%
36.8
38.0
25.1
19.6
49.3
31.1
28.3
56.8
14.9
19.0
22.2
0.4
20.6
26.6
11.1
41.3
36.3
22.4
•Total = 107.
t Total = 107.
t Total = 68.
§ Total = 505.
|| Sum does not add up correctly because of missing values.
TlOne drink corresponded to 150 mL of wine, 330 mL of beer, and 30 mL of hard liquor.
Results
Table 1 gives the distribution of patients
with UDT cancer and of controls accord-
ing to sociodemographic factors and
smoking and drinking habits. Table 2
shows this distribution according to con-
sumption of fresh fruits, vegetables, and
maize. Highly significant associations
with frequent intake of maize emerged for
all three tumor sites; age-adjusted odds
ratios were (for highest vs. lowest fre-
quency of consumption) 3.3 [95% confi-
dence interval (CI) = 2.0-5.4], 3.2 (95%
CI = 2.0-5.3), and 2.8 (95% CI =
1.5-5.1) for cancers of the oral cavity,
pharynx, and esophagus, respectively
(table 3). Maize was further included in a
multiple logistic regression equation, in-
cluding terms for age, education, occupa-
tion, tobacco use, and frequency of con-
sumption of fresh fruits and vegetables.
Although being a farmer turned out to be
an important confounder of the association
of maize with the development of UDT
cancers, all the trends in risk remained
significant (table 3).
The odds ratios were heterogeneous for
maize consumption across levels of alco-
hol intake, which led to the investigation
of the specific effects of maize intake on
consumers of alcohol (table 4). Consis-
tently for each tumor (not shown) and
overall, we found an elevated odds ratio
for highest versus lowest frequency of
maize intake in heavy drinkers (i.e., ^42
drinks/wk); this finding contrasted with
the apparent lack of effect in light drinkers
and abstainers from alcohol (table 4). Con-
versely, the pattern of risk for maize was
similar across various strata of sociodemo-
graphic factors, tobacco use, and intake of
fresh fruits and vegetables, thus suggest-
ing no appreciable modification of effect
(data not shown).
An attempt was made to explore maize
intake 10 years before diagnosis or (among
controls) before interview. Only 4% of the
patients reported a lower consumption of
maize in the past compared with the
present, whereas 30% of the patients with
oral and pharyngeal cancers, 50% of the
patients with esophageal cancer, and 33%
of the control subjects reported substan-
tially higher intake in the past.
Discussion
Our results from the northeastern part of
Italy not only are consistent with previous
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Table 2. Distribution of 282 patients with UDT cancers and 505 controls according
to consumption of various indicator foods: Pordenone, Italy, 1985-1989
Food
Fresh fruits (servings/wk)
< 4
5-12
>13
Vegetables (servings/wk)
<7
7-13
>14
Maize || (servings/wk)
Never-occasionally
1-2
>3
•Total = 107.
tTotal = 107.
tTotal = 68.
§ Total = 505.
|| Sum does not add up
Oral
No.*
40
30
37
24
30
53
54
20
33
cavity
%
37.4
28.0
34.6
22.4
28.0
49.5
50.5
18.7
30.8
Patients by site of cancer
Pharynx
No.t
43
25
39
22
21
64
53
21
33
correctly because of missing
%
40.2
23.4
36.4
20.6
19.6
59.8
49.5
19.6
30.8
vaJues.
Esophagus
No.t
30
18
20
18
22
28
37
12
19
%
44.1
26.5
29.4
26.5
32.4
41.2
54.4
17.6
27.9
Controls
No.§
153
144
208
71
134
300
351
84
69
%
30.3
28.5
41.2
14.1
263
59.4
69.6
16.7
13.7
Table 3. Odds ratios for UDT cancers associated with frequency of maize consumption:
Pordenone, Italy, 1985-1989
Cancer site
Oral cavity
Pharynx
Esophagus
All sites
Method
of statistical
analysis*
MH
MLR
MH
MLR
MH
MLR
MH
MLR
Odds ratio: frequency of consumption
of maize (servings/wk)t
Never-
occasionallyt
1
1
1-2
1.6(0.9-2.8)
1.5 (0.8-2.8)
1.7(1.0-2.9)
1.5 (0.8-2.8)
1.4(0.7-2.8)
1.2(0.6-2.6)
1.6(1.1-2.4)
1.4(0.9-2.2)
>3
3.3 (2.0-5.4)
25 (1.4-4.4)
3.2 (2.0-5.3)
2.5(1.4-4.4)
2.8(1.5-5.1)
2.1 (1.1-4.0)
3.2 (2.2-4.6)
2.3 (1.5-3.5)
trend
21.09§
9.21§
21.13§
10.34§
10.11§
4.42||
36.82§
15.6O§
*MH = Mantel-Haenszel estimates adjusted for age in decades; MLR = derived from multiple
logistic regression equations, including terms for age, education, occupation, tobacco use, and
frequency of consumption of fresh fruits, vegetables, and maize.
tNos. in parentheses in columns = 95% CIs.
t Reference category.
§/>< .01.|| P = .04.
Table 4. Odds ratios* for all UDT cancers associated with maize and alcohol consumption:
Pordenone, Italy, 1985-1989
Alcoholic
drinks/wk
<41
42-76
>77
Odds ratio:
Never-
occasionallyt
1
1
1
frequency of consumption
(servings/wk)
1-2
1.02
1.29
2.04
of maize
>3
0.72
2.52
2.90
trend
0.26
5.95t
10.00§
• Derived from multiple logistic regression equation, including terms for age, tobacco use, and
frequency of consumption of maize.
t Reference category.
tP=-02.
§/»< .01.
findings, but also offer an unprecedented
opportunity to investigate in depth the
joint effect of high exposure to dietary
maize and use of alcohol and tobacco.
Also new was the finding of the consis-
tency in the effect of high maize consump-
tion on the development of cancers of the
oral cavity, pharynx, and esophagus, at
least in the presence of a high prevalence
of smoking and alcohol consumption.
Several case-control studies have ex-
amined the effect of diet on the etiology of
UDT cancers, but the information on the
role of maize is scanty. Most investiga-
tions, including the present one, have
found that diets high in raw vegetables and
fresh fruits confer some protection against
oral and pharyngeal cancers (28-33) as
well as against esophageal cancer and pre-
cursor lesions (31,34-40).
Where it is common, maize emerges
consistently as an important risk factor, at
least for esophageal cancer. Van Rensburg
et al. (41) found a more than fivefold
elevated risk of developing esophageal
cancer among Zulu men who daily pur-
chased maize meals. Segal et al. (42)
observed in South Africa a 25-fold en-
hanced risk of developing esophageal can-
cer among heavy drinkers of traditional
beer made from maize. In Linxian, Peo-
ple's Republic of China, Li et al. (40)
detected a rather strong trend of increasing
risk of esophageal cancer with increasing
consumption of maize and wheat, but not
millet and sweet potatoes. Wahrendorf
et al. (39) found that in Henan, People's
Republic of China, frequent consumption
of maize enhanced cancer risk, even after
these investigators allowed for several
other risk factors. Finally, Rossi et al. (20)
reported a 4.5-fold increased risk of devel-
oping esophageal cancer among individu-
als who ate two or more slices of polenta
per day in an investigation conducted in
the Veneto region of Italy. This region
borders Pordenone Province and is eco-
nomically and historically similar to it.
By far, however, the strongest evidence
for the role of maize comes from surveys
in Africa. Maize is an introduced crop in
Africa, and its spread as a staple food and
an ingredient in traditional beer seems to
coincide (after one allows for a latent
period) with the rise in the frequency of
esophageal cancer (8,10,12,13). Maize is
easier to grow and more resistant to fungus
and attacks by birds than other grains.
However, particularly if it is refined,'
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maize is less nutritious than other grains
and can cause deficiencies of several mi-
cronutrients (chiefly, riboflavin and nia-
cin) (43).
Riboflavin deficiency has been sug-
gested as one of the deficiencies that cause
Plummer-Vinson syndrome, a long-
recognized precancerous lesion of the
UDT (6). Maize not only is low in niacin
and tryptophan (its precursor) but also
contains large quantities of leucine, which
is capable of interfering with oxidation-re-
duction reactions. Like the Plummer-
Vinson syndrome, pellagra, a life-threat-
ening disease caused by niacin deficiency,
can result in widespread inflammation of
the mucous surfaces, dysphagia, and
esophageal lesions (44).
The elevation in risk resulting from
frequent consumption of maize in the
present study could not be explained in
terms of the confounding effect of age,
education, occupation, tobacco use, or
consumption of fresh fruits and vegeta-
bles. However, the difference in the effect
of maize according to level of alcohol
consumption is highly significant. In other
words, the unfavorable impact of high
intake of maize found in the present study
seems to be relevant only in heavy drink-
ers. Long-term, high alcohol intake is seen
rather frequently in the male population of
Pordenone Province. It is often accompa-
nied by deficiencies of niacin and ribofla-
vin in the diet and, perhaps most impor-
tantly, by increases in micronutrient
requirements caused by high levels of eth-
anol oxidation (45). This observation may
explain the extraordinarily increased risk
of esophageal cancer observed in Africa
(8), in various parts of the United States
(29,34,46), and in northeastern Italy (20)
among individuals on diets low in nutri-
ents who consumed large quantities of
maize and alcoholic beverages.
Alcohol may aggravate the nutritional
deficiency induced by maize-rich diets.
Alternatively, mucosal lesions caused by
niacin and/or riboflavin deficiency may
enhance the topical action of alcohol, pos-
sibly favoring the penetration of carcino-
genic compounds (47). While we can only
speculate on such mechanisms, the present
data suggest that maize retains a role in the
etiology of UDT cancers even in devel-
oped areas of the world, where maize is
still a major staple food and/or where the
occurrence of alcohol-related diseases is
high.
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Clinical Pharmacokinetics of
High-Dose Leucovorin Calcium
After Intravenous and Oral
Administration
Richard L. Schilsky* MarkJ.
Ratain
The clinical formulation of leucovorin
calcium (leucovorin, LV) is a mixture of
stereoisomers [(6R,S)-5-formyltetrahy-
drofolate], which have been shown to
differ significantly in plasma clearance
and route of elimination after intrave-
nous administration; the (6S) isomer is
rapidly converted to 5-CH3 tetrahydro-
folate (5-CH3 THF), and the (6R) iso-
mer is slowly eliminated by renal excre-
tion. The relative importance of (6S) LV
and 5-CH3 THF in expanding reduced
folate pools in tumor cells is unknown,
but it is known that high concentrations
of (6R) LV can support growth of folate-
depleted cells and thus have the poten-
tial to interfere with the biological activ-
ity of the (6S) isomer. To examine the
pharmacokinetics of the LV isomers
and metabolites, we administered 1,000
mg of LV to five normal subjects as a
2-hour intravenous infusion and in di-
vided oral 100-mg doses given over 24
hours. Plasma and urine samples were
analyzed by reverse phase followed by
chiral high-performance liquid chro-
matography. Following intravenous ad-
ministration, peak plasma concentra-
tions of (6R) LV, (6S) LV, and 5-CH3
THF were 148 ± 32,59.1 ± 22, and 17.8
± 17 \iAf, respectively. During oral ad-
ministration of LV, virtually no (6S) LV
appeared in the plasma. Steady-state
plasma concentrations of (6R) LV and
5-CH3 THF were approximately 1.5 ±
0.23 and 2.8 ± 0.41 JJLM, respectively.
Intravenous administration of LV re-
sulted in an area under the curve (AUC)
for (6R) LV that was more than four
times that of the biologically active (6S)
folates, whereas oral administration
produced an AUC for (6S) reduced fo-
lates [(6S) LV and 5-CH3 THF] that was
approximately twice that of (6R) LV.
After administration of high doses of
LV intravenously, conversion of (6S)
LV to 5-CH3 THF was saturable, as
indicated by the prolonged (6S) LV half-
life of 58 minutes and the slow (6S) LV
clearance of 119.2 ± 38 mL/min, com-
pared with previously reported data for
administration of low doses. This study
illustrates that intravenous administra-
tion of LV produces equivalent AUCs of
(6S) LV and 5-CH3 THF but a substan-
tially higher AUC for (6R) LV. Oral
administration over 24 hours results in
an AUC of 5-CH3 THF equivalent to
that obtained after intravenous dosing
in the presence of only small amounts of
(6R) LV. The optimal route of LV ad-
ministration will ultimately be deter-
mined by ongoing studies of the cellular
pharmacology of LV that will determine
if high concentrations of (6R) LV inter-
fere with the biological activity of the
(6S) reduced folates. [J Natl Cancer Inst
82:1411-1415,1990]
Leucovorin calcium ([6R,S]-5-formyl-
tetrahydrofolate, LV) is a reduced folate
that has been used for many years to
prevent toxic effects after intermediate-
and high-dose methotrexate therapy. Re-
cent experimental and clinical data indi-
cate that leucovorin also plays an impor-
tant role in modulating the cytotoxicity of
the pyrimidine antimetabolite fluorouracil
(5-FU). Exposure of tumor cells to LV in
vitro results in expanded intracellular
pools of 5-10CH2-tetrahydrofolate and sta-
bilization of the ternary complex formed
by this folate cofactor, thymidylate syn-
thase, and 5-fluorodeoxyuridylate..The re-
sults are sustained inhibition of thymi-
dylate synthesis and enhanced cytotoxicity
(7-6). A number of clinical trials compar-
ing the combination of 5-FU and LV to
5-FU alone have clearly demonstrated im-
proved response "rates and survival for
patients with advanced colorectal cancer
receiving the two-drug combination (7-10).
Despite the clinical success of treatment
with 5-FU plus LV, the optimal dose,
route, and schedule of LV administration
have not yet been clearly defined. Preclin-
ical studies suggest that (6S) LV concen-
trations in the range of 1-10 \iM are
necessary to optimally enhance the cyto-
toxicity of 5-FU in vitro (2,4,5). How-
ever, these studies have generally not
considered the unique pharmacologic
characteristics of LV that become apparent
in vivo due to drug metabolism and the
existence of LV stereoisomers.
The clinical formulation of LV is a
mixture of stereoisomers around the C6
carbon of the pteridine ring, with most of
the biological activity confined to the (6S)
isomer. The individual isomers differ sig-
nificantly in their plasma clearance and
route of elimination after intravenous ad-
ministration, with the (6S) isomer being
rapidly converted to 5-CH3-tetrahydro-
folate (5-CH3 THF) and the (6R) isomer
being slowly eliminated by renal excretion
(11-13). The relative importance of (6S)
LV and 5-CH3 THF in expanding reduced
folate pools in human tumors is unknown,
and the potential for high concentrations of
(6R) LV to interfere with the biological
activity of the (6S) isomer must be consid-
ered, in view of the fact that (6R) LV can
gain entry into cells and, in high concen-
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